Heme oxygenase‐1: a new therapeutic target for inflammatory bowel disease
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Summary: Heme oxygenase (HO) is the rate‐limiting enzyme in the catabolism of heme, followed by production of biliverdin, free iron and carbon monoxide (CO). Three mammalian HO isozymes have been identified, one of which, HO‐1, is a stress‐responsive protein induced by various oxidative agents. HO‐2 and HO‐3 genes are constitutively expressed. Recent studies demonstrate that the expression of HO‐1 in response to different inflammatory mediators may contribute to the resolution of inflammation and have protective effects in several organs against oxidative injury. Although the mechanism underlying the anti‐inflammatory actions of HO‐1 remains poorly defined, both CO and biliverdin/bilirubin have been implicated in this response. In the intestinal tract, HO‐1 is shown to be transcriptionally induced in response to oxidative stress, preconditioning and acute inflammation. Recent studies suggest that the induction of HO‐1 expression plays a critical protective role in intestinal damage models induced by trinitrobenzene sulphonic acid or dextran sulphate sodium, indicating that activation of HO‐1 may act as an endogenous defensive mechanism to reduce inflammation and tissue injury in the intestinal tract. These in vitro and in vivo data suggest that HO‐1 may be a novel therapeutic target in patients with inflammatory bowel disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice
Lee, T.-S., & Chau, L.-Y. (2002) · Nature Medicine · doi:10.1038/nm0302-240 · Cited by 1,019
Cited by
Carbon Monoxide: Endogenous Production, Physiological Functions, and Pharmacological Applications
Wu, L., & Wang, R. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.4.3 · Cited by 962
Heme Oxygenase-1 Signaling and Redox Homeostasis in Physiopathological Conditions
Consoli, V., Sorrenti, V., Grosso, S., & Vanella, L. (2021) · Biomolecules · doi:10.3390/biom11040589 · Cited by 284
Megías, J., Busserolles, J., & Alcaraz, M. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707184 · Cited by 117
“a new therapeutic target for inflammatory bowel disease (Naito et al., 2004).”
BackgroundHirata, I., Naito, Y., Takagi, T., Mizushima, K., Suzuki, T., Omatsu, T., Handa, O., Ichikawa, H., Ueda, H., & Yoshikawa, T. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1461-5 · Cited by 72
Self-citationOral nitrite ameliorates dextran sulfate sodium-induced acute experimental colitis in mice
Ohtake, K., Koga, M., Uchida, H., Sonoda, K., Ito, J., Uchida, M., Natsume, H., & Kobayashi, J. (2010) · Nitric Oxide · doi:10.1016/j.niox.2010.04.004 · Cited by 48
Metadata
- Authors
- Naito, Y., Takagi, T., & Yoshikawa, T.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2004-07
- Volume
- 20
- Issue
- s1
- Pages
- 177-184
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2088126217
- Cited by
- 91
- References
- 1
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Heme oxygenase‐1: a new therapeutic target for inflammatory bowel disease. https://app.cochat.ai/papers/10.1111/j.1365-2036.2004.01992.x
- The paper
- Naito, Y., Takagi, T., & Yoshikawa, T. (2004). Heme oxygenase‐1: a new therapeutic target for inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2004.01992.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.